These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 17045832)

  • 1. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
    Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
    Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
    Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
    Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.
    Ling Z; Liu X; Chen W; Luo Y; Yuan L; Xia Y; Nelson KE; Huang S; Zhang S; Wang Y; Yuan J; Li L; Xiang C
    Microb Ecol; 2013 Apr; 65(3):773-80. PubMed ID: 23250116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
    Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
    Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
    Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
    BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
    Vicariotto F; Mogna L; Del Piano M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
    Russo R; Karadja E; De Seta F
    Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing.
    van de Wijgert JHHM; Verwijs MC; Agaba SK; Bronowski C; Mwambarangwe L; Uwineza M; Lievens E; Nivoliez A; Ravel J; Darby AC
    Sci Rep; 2020 Mar; 10(1):3884. PubMed ID: 32127550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli.
    Reid G; Burton J; Hammond JA; Bruce AW
    J Med Food; 2004; 7(2):223-8. PubMed ID: 15298771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.
    Martinez RC; Franceschini SA; Patta MC; Quintana SM; Gomes BC; De Martinis EC; Reid G
    Can J Microbiol; 2009 Feb; 55(2):133-8. PubMed ID: 19295645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
    Laue C; Papazova E; Liesegang A; Pannenbeckers A; Arendarski P; Linnerth B; Domig KJ; Kneifel W; Petricevic L; Schrezenmeir J
    Benef Microbes; 2018 Jan; 9(1):35-50. PubMed ID: 29065710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oral Probiotic
    Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.